Ping F. Shi
State Key Laboratory Of Bioreactor Engineering
Shanghai, 200237, China
Shanghai, 200237, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Clioquinol inactivates thiamine pyrophosphate by increasing cellular oxidative stress.
Journal: Redox biology
Published: May 08, 2026
Hydroxyl-radical-specific cascade photogeneration for oxygen-chain photocatalytic therapy.
Journal: Chemical science
Published: April 21, 2026
Current status of premature myocardial infarction research in China: a systematic review and international comparative perspective.
Journal: Frontiers in cardiovascular medicine
Published: April 17, 2026
PEGylated Graphene Oxide as a Nanocarrier Assists Alpha Lipoic Acid Mitigating Hypoxia Induced Mitochondrial Dysfunction.
Journal: ACS applied bio materials
Published: January 14, 2026
The dual role of Rpt3 in protecting cells from proteotoxic damage.
Journal: The FEBS journal
Published: December 23, 2025
4-MEC potentially triggers CAV1 via the BDNF-TrkB signaling pathway.
Journal: Molecular and cellular neurosciences
Published: August 21, 2025
Challenges and future prospects of the 2D material-based composites for microwave absorption.
Journal: Nanoscale
Published: May 20, 2025
Fluorescence lifetime clocks quantify senescence and aging.
Journal: Nature aging
Published: April 02, 2025
Identification and pharmacological properties of 2-(1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-INACA), N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide (ADB-INACA), and N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazole-3-carboxamide (ADB-HINACA).
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 05, 2024
Analysis and summary of clinical characteristics of 289 patients with paroxysmal nocturnal hemoglobinuria in Zhejiang Province
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 12, 2024
Targeting intracellular cancer proteins with tumor-microenvironment-responsive bispecific nanobody-PROTACs for enhanced therapeutic efficacy.
Journal: MedComm
Published: July 02, 2024
Last Updated: 09/26/2026